FDA cancels vaccine advisory meeting for choosing flu shots

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A crucial March meeting of vaccine advisors to the Food and Drug Administration has been canceled without explanation, a member of the advisory panel told CNBC on Wednesday.  The meeting … Read more

Teladoc (TDOC) Q4 earnings 2025

Teladoc Health Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, Dec. 31, 2024.  Michael Nagle | Bloomberg | Getty Images Teladoc Health shares fell in extended trading on Wednesday after the company reported a wider loss than analysts expected and issued disappointing quarterly guidance. Here’s … Read more

A child dies of measles in West Texas outbreak

A sign reading “measles testing” is seen as an outbreak in Gaines County, Texas, has raised concerns over its spread to other parts of the state, in Seminole, Texas, U.S., Feb. 25, 2025. Sebastian Rocandio | Reuters A school-age child has died of measles in West Texas, the first death from the disease in a … Read more

What Cramer wants to hear from Nvidia, Salesforce — plus, Lilly does what no other can

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. The broader market rebounded Wednesday, with the S & P 500 and Nasdaq trying to snap their four-day losing streaks. The Dow was on pace for its third straight … Read more

Eli Lilly to invest $27 billion in new U.S. manufacturing

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes … Read more

Hims & Hers shares plunge 28% on concerns over weight loss business

Shares of Hims & Hers Health closed down 22% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business. Hims & Hers reported $481 million in revenue for the quarter, up 95% from $246.6 million during the same … Read more

HHS Secretary RFK Jr.’s efforts could affect vaccines

Robert F. Kennedy Jr., U.S. President Trump’s nominee to be Secretary of Health and Human Services, testifies before a Senate Finance Committee confirmation hearing on Capitol Hill in Washington, U.S., Jan. 29, 2025.  Nathan Howard | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news … Read more

Eli Lilly offers higher Zepbound weight loss drug doses on LillyDirect

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without … Read more

Athenahealth to offer Abridge’s AI scribe to its network of thousands of doctors

A doctor looks at an AI-generated clinical note. Courtesy of Athenahealth Health-care software vendor Athenahealth on Tuesday said it will offer Abridge’s artificial intelligence scribing tool to its network of more than 160,000 clinicians.  Athenahealth has developed an electronic health record, revenue cycle management tools and patient engagement tools for ambulatory care providers, which include … Read more

Hims & Hers Health (HIMS) Q4 earnings 2024

Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here’s how the company did, compared to analysts’ consensus estimates from LSEG: Earnings per share: 11 cents vs. 10 cents expected Revenue: $481 million vs. $470 million expected … Read more